Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any hypertrophic cardiomyopathy in which the cause of the disease is a mutation in the TNNI3 gene.
Features include always present findings: Thickened heart muscle (hypertrophic cardiomyopathy); and common findings: Wolff-Parkinson-White syndrome and Apical hypertrophic cardiomyopathy. 5 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 4 | Thickened heart muscle (hypertrophic cardiomyopathy), Atrial fibrillation, Apical hypertrophic cardiomyopathy |
TNNI3 function has not been fully characterized.
Hypertrophic cardiomyopathy 7 is associated with mutations in the TNNI3 gene on chromosome 19.
Genetic testing for TNNI3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for hypertrophic cardiomyopathy 7 has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 2 common features.
No clinical trials have been registered for hypertrophic cardiomyopathy 7.
279 publications have been identified in PubMed for hypertrophic cardiomyopathy 7. Research spans Epidemiology / Natural History (23%), Review / Meta-Analysis (18%), and Clinical Trial Publication (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 65 | 23% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:57 PM UTC
Online Mendelian Inheritance in Man
Brain and nerves |
1 |
Wolff-Parkinson-White syndrome |
Research summaries
49 |
18% |
Clinical study results | 49 | 18% |
Laboratory research | 46 | 16% |
Testing and diagnosis research | 38 | 14% |
Other research | 13 | 5% |
New treatment approaches | 10 | 4% |
Patient case studies | 9 | 3% |
Nassif ME (2026). [PMID: 41493295](https://pubmed.ncbi.nlm.nih.gov/41493295/). *J Am Coll Cardiol*. [Clinical Trial Publication]
Pietsch N (2026). [PMID: 41202843](https://pubmed.ncbi.nlm.nih.gov/41202843/). *Annu Rev Physiol*. [Review / Meta-Analysis]
Bakalakos A (2026). [PMID: 42268168](https://pubmed.ncbi.nlm.nih.gov/42268168/). *JACC Heart Fail*. [Diagnostic / Biomarker]
Minette F (2026). [PMID: 41081838](https://pubmed.ncbi.nlm.nih.gov/41081838/). *Clin Res Cardiol*. [Epidemiology / Natural History]
Francia P (2026). [PMID: 41150638](https://pubmed.ncbi.nlm.nih.gov/41150638/). *Eur Heart J Cardiovasc Imaging*. [Diagnostic / Biomarker]
Palamattam DJ (2026). [PMID: 41613485](https://pubmed.ncbi.nlm.nih.gov/41613485/). *Indian J Thorac Cardiovasc Surg*. [Review / Meta-Analysis]
Micheu MM (2026). [PMID: 41977344](https://pubmed.ncbi.nlm.nih.gov/41977344/). *Int J Mol Sci*. [Review / Meta-Analysis]
Jain SS (2026). [PMID: 41213043](https://pubmed.ncbi.nlm.nih.gov/41213043/). *JAMA Cardiol*. [Clinical Trial Publication]
Erzeel J (2026). [PMID: 41885188](https://pubmed.ncbi.nlm.nih.gov/41885188/). *ESC Heart Fail*. [Diagnostic / Biomarker]
Bilen O (2026). [PMID: 41212168](https://pubmed.ncbi.nlm.nih.gov/41212168/). *Circ Genom Precis Med*. [Epidemiology / Natural History]